10.57647/pibm.2024.132411

Synthesis and Kinetic Study of Ion-Doped Zif-8 Nanocarriers for a Flutamide Delivery

  1. Department of Chemistry, NT.C., Islamic Azad University, Tehran, Iran
  2. Department of Chemistry, TeMS.C., Islamic Azad University, Tehran, Iran
  3. Department of Pharmaceutical Chemistry, TeMS.C., Islamic Azad University, Tehran, Iran

Published in Issue 2024-09-30

How to Cite

Gilianinezhad, N., Pasdar, H., Yousefi, M., Saber-Tehrani, M., & Hekmati, M. (2024). Synthesis and Kinetic Study of Ion-Doped Zif-8 Nanocarriers for a Flutamide Delivery. Progress in Biomaterials, 13(03). https://doi.org/10.57647/pibm.2024.132411

Abstract

Here, we describe characterization of new Zif-8 composites doped with magnetite (Fe3O4) and gold (Au) nanoparticles, labeled Zif-8-Fe and Zif-8-Au, to precisely tune their release kinetics, drug loading, and porosity. Geometry modification was observed in SEM images  after ion doping, with the mean size ranging from 50-80 nm for Zif-8 and Zif-8-Au and about 500 nm for Zif-8-Fe. A clear XRD peak shift confirmed the successful incorporation of dopant ions. Brunauer-Emmett-Teller (BET) analysis revealed that while Au doping  significantly reduced the material’s surface area and pore volume, Fe doping remarkably enhanced these properties (556 vs 2676 m2/g and 0.26 vs 1 cm3/g, respectively). This directly impacted drug loading, with the Zif-8-Fe composite demonstrating the highest loading capacity (18.8 mg/g) and Zif-8-Au showing the lowest (7.2 mg/g). In vitro drug release studies further demonstrated distinct kinetic profiles. The release from all samples followed a Fickian diffusion mechanism, as indicated by the Korsmeyer-Peppas model (n ≈ 0.01 − 0.05). The Zif-8-Fe composite exhibited a desirable sustained-release profile due to its enhanced and more tortuous pore network, while the Zif-8-Au composite showed low-quantity release. The findings demonstrated that ion doping provided a powerful strategy to engineer the structural properties and drug release kinetics of MOFs.

Keywords

  • Nanoparticles,
  • Drug delivery,
  • Metal–organic framework (MOF),
  • Cancer therapy